Fundraising FoxJuventas Therapeutics
Cleveland, US · Founded 2007 · Delaware corporation · 6 known investors
Find your way into Juventas Therapeutics
Sign up to see every warm intro you have to Juventas Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Juventas Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Juventas Therapeutics was founded in 2007 by Marc Penn.
MP
Marc PennFounder
TI
Troy IgnelziExecutiveTroy Ignelzi is an executive with experience in finance, operations, and business development, including capital raising, mergers and acquisitions, and regulatory negotiations for FDA-approved products.
RA
Rahul ArasNamed on SEC filing
Board
Investors · 6
Clarevia VenturesreportedMadison · $250K – $2.5M
How we know: funding news · Not right? Tell us
Early Stage Partners, LPreportedCleveland
How we know: funding news · Not right? Tell us
New Science VenturesreportedGreenwich · $2M – $8M
How we know: funding news · Not right? Tell us
Takeda VenturesreportedCambridge · $1M – $5M
How we know: funding news · Not right? Tell us
Triathlon Medical Venture Partnersreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.7M disclosed across 3 rounds · 2008–2017
▶$1.3MraisedOct 2017 · 46 investors · BiotechnologyRule 506(b)
▶$1.3MraisedOct 2017 · 46 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew PollmanExecutive Officer, Director
- Linda TuftsDirector
- George AridaDirector
- James BolandDirector
- Suzette DutchDirector
- Rahul ArasExecutive Officer, Director
- Roger NewtonDirector
- Jack MinerDirector
- Offering amount
- $6M
- Amount sold
- $1.3M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedMay 2015 · 37 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMay 2015 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Suzette DutchDirector
- Marc PennExecutive Officer, Director
- Roger NewtonDirector
- George AridaDirector
- Linda TuftsDirector
- Matthew PollmanDirector
- Troy IgnelziExecutive Officer
- Rahul ArasExecutive Officer, Director
- James BolandDirector
- Somu SubramaniamDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedFeb 2012 · 34 investors · BiotechnologyRule 506(b)
▶$12MraisedFeb 2012 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somu SubramaniamDirector
- Matt PollmanDirector
- Rahul ArasExecutive Officer, Director
- Roger NewtonDirector
- Linda TuftsDirector
- Marc PennDirector
- George EmontDirector
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- Sep 2008
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Juventas Therapeutics?
- Juventas Therapeutics was founded by Marc Penn in 2007.
- Who are Juventas Therapeutics's investors?
- Juventas Therapeutics's investors include Panacea Venture, Clarevia Ventures, Early Stage Partners, LP, New Science Ventures, Takeda Ventures, Triathlon Medical Venture Partners.
- How much funding has Juventas Therapeutics raised?
- Juventas Therapeutics has disclosed $20.7M raised across 3 rounds.
- Where is Juventas Therapeutics headquartered?
- Juventas Therapeutics is headquartered in Cleveland, US.